NO20052787D0 - N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents - Google Patents

N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents

Info

Publication number
NO20052787D0
NO20052787D0 NO20052787A NO20052787A NO20052787D0 NO 20052787 D0 NO20052787 D0 NO 20052787D0 NO 20052787 A NO20052787 A NO 20052787A NO 20052787 A NO20052787 A NO 20052787A NO 20052787 D0 NO20052787 D0 NO 20052787D0
Authority
NO
Norway
Prior art keywords
methyleneamino
pyridones
hydroxy
alkyl
antimicrobial agents
Prior art date
Application number
NO20052787A
Other languages
Norwegian (no)
Other versions
NO20052787L (en
NO330810B1 (en
Inventor
Rodney Dean Bush
Namal Chithranga Warshakoon
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20052787D0 publication Critical patent/NO20052787D0/en
Publication of NO20052787L publication Critical patent/NO20052787L/en
Publication of NO330810B1 publication Critical patent/NO330810B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Compounds of Formula (I) are effective in the treatment of a microbial infection.
NO20052787A 2002-11-09 2005-06-09 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents NO330810B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42507002P 2002-11-09 2002-11-09
PCT/US2003/035622 WO2004043927A1 (en) 2002-11-09 2003-11-07 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials

Publications (3)

Publication Number Publication Date
NO20052787D0 true NO20052787D0 (en) 2005-06-09
NO20052787L NO20052787L (en) 2005-06-09
NO330810B1 NO330810B1 (en) 2011-07-25

Family

ID=32312926

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052787A NO330810B1 (en) 2002-11-09 2005-06-09 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents

Country Status (26)

Country Link
US (5) US6930117B2 (en)
EP (1) EP1558579B1 (en)
JP (1) JP4496083B2 (en)
KR (2) KR20050055792A (en)
CN (1) CN1708481A (en)
AT (1) ATE372985T1 (en)
AU (1) AU2003291382B2 (en)
BR (1) BR0316107A (en)
CA (1) CA2502264C (en)
CO (1) CO5570678A2 (en)
CY (1) CY1106958T1 (en)
DE (1) DE60316338T2 (en)
DK (1) DK1558579T3 (en)
EG (1) EG25017A (en)
ES (1) ES2293036T3 (en)
HR (1) HRP20050516B1 (en)
IL (1) IL168119A (en)
MA (1) MA27643A1 (en)
MX (1) MXPA05004896A (en)
NO (1) NO330810B1 (en)
NZ (1) NZ539386A (en)
PL (1) PL377226A1 (en)
PT (1) PT1558579E (en)
RU (1) RU2311410C2 (en)
WO (1) WO2004043927A1 (en)
ZA (1) ZA200503683B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6930117B2 (en) * 2002-11-09 2005-08-16 The Procter & Gamble Company N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
ES2524922T3 (en) 2005-05-10 2014-12-15 Intermune, Inc. Pyridone derivatives to modulate the stress-activated protein kinase system
US7973060B2 (en) 2005-10-13 2011-07-05 Crystalgenomics, Inc. Fab I inhibitor and process for preparing same
AR059898A1 (en) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv DERIVATIVES OF 3-CIANO-PIRIDONA 1,4-DISUSTITUTED AND ITS USE AS ALLOSTERIC MODULATORS OF MGLUR2 RECEIVERS
US7622593B2 (en) 2006-06-27 2009-11-24 The Procter & Gamble Company Human protein tyrosine phosphatase inhibitors and methods of use
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
NZ584152A (en) 2007-09-14 2011-11-25 Ortho Mcneil Janssen Pharm 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
KR101520086B1 (en) 2007-09-14 2015-05-14 얀센 파마슈티칼스 인코포레이티드 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2'-ones
KR20100080597A (en) 2007-09-14 2010-07-09 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 1,3-disubstituted-4-phenyl-1h-pyridin-2-ones
JP5433582B2 (en) 2007-11-14 2014-03-05 ジャンセン ファーマシューティカルズ， インコーポレイテッド． Imidazo [1,2-a] pyridine derivatives and their use as positive allosteric modulators of the mGluR2 receptor
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
CA2735764C (en) 2008-09-02 2016-06-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
US8697689B2 (en) 2008-10-16 2014-04-15 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
US8691813B2 (en) 2008-11-28 2014-04-08 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
BRPI1012870B8 (en) 2009-05-12 2021-05-25 Addex Pharmaceuticals Sa 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors and pharmaceutical composition
EA020671B1 (en) 2009-05-12 2014-12-30 Янссен Фармасьютикалз, Инк. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF mGluR2 RECEPTORS
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY160399A (en) 2009-07-06 2017-03-15 Aerpio Therapeutics Inc Compounds, compositions, and methods for preventing metastasis of cancer cells
EP2496236B1 (en) * 2009-11-06 2013-05-01 Aerpio Therapeutics Inc. Prolyl hydroxylase inhibitors
NO2542084T3 (en) 2010-03-04 2018-05-19
EP2542077A4 (en) * 2010-03-04 2013-08-21 Merck Sharp & Dohme Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
PT2649069E (en) 2010-11-08 2015-11-20 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US9012448B2 (en) 2010-11-08 2015-04-21 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
AR092742A1 (en) 2012-10-02 2015-04-29 Intermune Inc ANTIFIBROTIC PYRIDINONES
AU2014233363B2 (en) 2013-03-15 2017-06-29 EyePoint Pharmaceuticals, Inc. Compositions, formulations and methods for treating ocular diseases
US20150050277A1 (en) 2013-03-15 2015-02-19 Aerpio Therapeutics Inc. Compositions and methods for treating ocular diseases
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
KR102502485B1 (en) 2014-01-21 2023-02-21 얀센 파마슈티카 엔.브이. Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
ME03518B (en) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
ES2739625T3 (en) 2014-02-19 2020-02-03 Aerpio Therapeutics Inc Process for the preparation of N-benzyl-3-hydroxy-4-substituted-pyridin-2- (1 H) -ones
JP6483148B2 (en) 2014-03-14 2019-03-13 エアーピオ セラピューティクス インコーポレイテッド HPTP-β inhibitor
US10233195B2 (en) 2014-04-02 2019-03-19 Intermune, Inc. Anti-fibrotic pyridinones
US9539245B2 (en) 2014-08-07 2017-01-10 Aerpio Therapeutics, Inc. Combination of immunotherapies with activators of Tie-2
CN106146395B (en) 2015-03-27 2019-01-01 沈阳三生制药有限责任公司 3- hydroxypyridine compound, preparation method and its pharmaceutical applications
JP7051829B2 (en) 2016-06-13 2022-04-11 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド Substituted pyridine as an inhibitor of DNMT1

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US385390A (en) 1888-07-03 Sylvantjs l
US3852900A (en) * 1973-07-18 1974-12-10 J Svec Disc type indicia recording and display device
US3853900A (en) * 1973-09-14 1974-12-10 Searle & Co 4-benzyloxy-2 (1h)-pyridones
DE2442714A1 (en) * 1974-09-06 1976-03-18 Benckiser Wassertechnik Joh A Method and device for pumping liquids by means of a diaphragm metering pump
US5358949A (en) * 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
DE4316077A1 (en) * 1993-05-13 1994-11-17 Bayer Ag Substituted mono- and bihydridylmethylpyridones
US5789426A (en) * 1995-01-20 1998-08-04 Cornell Research Foundation, Inc. Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
US6046219A (en) * 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5849587A (en) * 1995-06-09 1998-12-15 Cornell Research Foundation, Inc. Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
US6977266B2 (en) 2000-12-28 2005-12-20 Shionogi & Co., Ltd. Pyridone derivatives having affinity for cannabinoid 2-type receptor
US6930117B2 (en) 2002-11-09 2005-08-16 The Procter & Gamble Company N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
US6946479B2 (en) * 2002-11-09 2005-09-20 The Procter & Gamble Company N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones

Also Published As

Publication number Publication date
RU2005114489A (en) 2005-11-20
US7790748B2 (en) 2010-09-07
CY1106958T1 (en) 2012-09-26
EP1558579B1 (en) 2007-09-12
CN1708481A (en) 2005-12-14
US7247648B2 (en) 2007-07-24
KR20050055792A (en) 2005-06-13
NO20052787L (en) 2005-06-09
AU2003291382B2 (en) 2008-07-31
NZ539386A (en) 2008-02-29
NO330810B1 (en) 2011-07-25
ATE372985T1 (en) 2007-09-15
RU2311410C2 (en) 2007-11-27
DE60316338D1 (en) 2007-10-25
KR20070026891A (en) 2007-03-08
US20100305097A1 (en) 2010-12-02
HRP20050516B1 (en) 2013-11-08
IL168119A (en) 2011-11-30
PL377226A1 (en) 2006-01-23
EG25017A (en) 2011-05-25
WO2004043927A1 (en) 2004-05-27
JP2006508133A (en) 2006-03-09
DE60316338T2 (en) 2008-06-05
PT1558579E (en) 2007-11-27
US20050234045A1 (en) 2005-10-20
US20070270407A1 (en) 2007-11-22
CO5570678A2 (en) 2005-10-31
CA2502264C (en) 2009-12-15
ES2293036T3 (en) 2008-03-16
DK1558579T3 (en) 2008-01-14
EP1558579A1 (en) 2005-08-03
CA2502264A1 (en) 2004-05-27
JP4496083B2 (en) 2010-07-07
BR0316107A (en) 2005-09-27
AU2003291382A1 (en) 2004-06-03
ZA200503683B (en) 2006-08-30
US20040097560A1 (en) 2004-05-20
HRP20050516A2 (en) 2005-12-31
US20120115876A1 (en) 2012-05-10
US6930117B2 (en) 2005-08-16
KR100896675B1 (en) 2009-05-08
MXPA05004896A (en) 2005-07-22
MA27643A1 (en) 2005-12-01
US8133894B2 (en) 2012-03-13

Similar Documents

Publication Publication Date Title
NO20052787D0 (en) N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
NO20052788L (en) N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
NO20051082L (en) Antimicrobial quinolones, their compositions and applications
ECSP003699A (en) FAB I INHIBITORS
DE60131138D1 (en) ANTIBACTERIAL AGENTS
NO20044995L (en) Heterocyclic compounds
DE60334536D1 (en) FURYLVERBINDUNGEN
NO20062629L (en) Oxazole derivatives of tetracklines
ATE516022T1 (en) ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF
DE60333746D1 (en) thienyl compounds
DK1709044T3 (en) Oxazolidinone-quinolone hybrid antibiotics
ATE511352T1 (en) ANTIMICROBIAL COMPOSITIONS
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
MXPA06000372A (en) Silicon compounds and their use.
DK1648906T3 (en) Organo-silicon compounds and their use
MXPA05009243A (en) N-aryl-2-oxazolidinone-5-carboxamides derivatives with antibacterial activity.
FI20020507A0 (en) Antimicrobial agent against pathogenic bacteria

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees